Bill > S00011

This bill requires medical providers and testing entities to provide comprehensive, clear information about non-invasive prenatal screening (NIPS), which are tests used to assess a fetus's risk of chromosomal abnormalities. The bill mandates that patients receive written notices before, during, and with test results, explicitly explaining that these screenings are risk assessments, not definitive diagnostic tests. The notices must clearly state that high-risk or low-risk screening results do not guarantee a positive or negative diagnosis, and any positive screening result should be followed by confirmatory diagnostic testing. Additionally, the New York State health commissioner must develop and make publicly available multilingual informational materials about NIPS, including current recommendations from professional medical organizations like ACOG, SMFM, and ACMG. The materials must also list FDA and New York State-approved screening tests, their performance characteristics, and emphasize that these tests are screening tools intended to indicate potential genetic risks, not to definitively diagnose genetic abnormalities. The bill does not limit healthcare practitioners' ability to recommend testing based on their professional judgment, and will take effect 180 days after becoming law.

Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S11